- Report
- March 2024
- 186 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- October 2019
- 107 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2021
- 155 Pages
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- March 2022
Global
From €4671EUR$4,850USD£4,017GBP
- Report
- March 2021
United States, Europe, ... United States, Europe, Japan
From €915EUR$950USD£787GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €915EUR$950USD£787GBP
The Albumin Test is a type of In Vitro Diagnostics (IVD) test used to measure the amount of albumin in a patient's blood. Albumin is a protein produced by the liver and is an important indicator of overall health. Low levels of albumin can indicate liver or kidney disease, malnutrition, or other health issues. The Albumin Test is used to diagnose and monitor these conditions.
The Albumin Test market is a subset of the larger IVD market, which is estimated to be worth billions of dollars. The Albumin Test market is expected to grow in the coming years due to the increasing prevalence of chronic diseases and the need for more accurate and reliable diagnostic tests.
Some of the major companies in the Albumin Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Show Less Read more
